WIM
Woodford Investment Management Portfolio holdings
AUM
$310M
This Quarter Return
-13.56%
1 Year Return
-17.41%
3 Year Return
-27.69%
5 Year Return
+67.02%
10 Year Return
–
AUM
$1.16B
AUM Growth
+$1.16B
(-7.9%)
Cap. Flow
+$94.4M
Cap. Flow
% of AUM
8.17%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
5
Reduced
2
Closed
–
Top Buys
| 1 |
AUTL
Autolus Therapeutics
AUTL
|
$36.1M |
| 2 |
Agios Pharmaceuticals
AGIO
|
$30.4M |
| 3 |
NCNA
NuCana
NCNA
|
$18.7M |
| 4 |
Theravance Biopharma
TBPH
|
$15.9M |
| 5 |
NITE
Nightstar Therapeutics plc American Depositary Shares
NITE
|
$14.3M |
Top Sells
| 1 |
Biogen
BIIB
|
$20.5M |
| 2 |
Alkermes
ALKS
|
$590K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUTL
1
Autolus Therapeutics
AUTL
$399M
| $392M | 33.87% | 11,925,419 +1,099,500 | +10% | +$36.1M |
|
|
2
Theravance Biopharma
TBPH
$699M
| $315M | 27.26% | 12,316,529 +621,650 | +5% | +$15.9M |
|
3
Prothena Corp
PRTA
$441M
| $123M | 10.62% | 11,924,614 | – | – |
|
|
4
Agios Pharmaceuticals
AGIO
$2.19B
| $91.2M | 7.89% | 1,977,459 +660,000 | +50% | +$30.4M |
|
|
5
Alkermes
ALKS
$4.78B
| $77.9M | 6.74% | 2,639,676 -20,000 | -0.8% | -$590K |
|
|
6
Biogen
BIIB
$19.4B
| $68.2M | 5.9% | 226,564 -68,000 | -23% | -$20.5M |
|
|
EVFM
7
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $40.2M | 3.48% | 9,593,197 | – | – |
|
|
NCNA
8
NuCana
NCNA
$6.09M
| $27M | 2.34% | 1,865,000 +1,293,000 | +226% | +$18.7M |
|
|
NITE
9
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
| $22.1M | 1.91% | 1,921,315 +1,239,206 | +182% | +$14.3M |
|